240 research outputs found
Cognitive Insight in Youth at Clinical High Risk of Psychosis
Introduction: Cognitive insight reflects oneâs Self-Reflectiveness (recognition of dysfunctional reasoning, corrigibility) and Self-Certainty (overconfidence). In schizophrenia, lower Self-Reflectiveness and higher Self-Certainty has been associated with severity of symptoms and poor functioning. There is some evidence that lower Self-Reflectiveness and higher Self-Certainty are associated with attenuated symptoms in youth at clinical high risk (CHR) of psychosis. The present study evaluated in a CHR sample the relationship between cognitive insight and attenuated symptoms, current functioning, and evaluated change in cognitive insight at baseline and 1-month follow-up. Methods: Twenty-four individuals at CHR of psychosis completed the Beck Cognitive Insight Scale. Attenuated psychotic symptoms were assessed with the Scale of Prodromal Symptoms and functioning with the Global Functioning Social and Role scales. A subset of the sample completed the Calgary Depression Scale for Schizophrenia. Self-Reflectiveness, Self-Certainty, and Composite Index scores were correlated with clinical and functional variables. In addition, cognitive insight levels were compared at baseline and 1-month follow-up. Results: Trends were observed toward both increased attenuated perceptual abnormalities/hallucinations and higher Self-Reflectiveness, and increased avolition and increased Self-Reflectiveness. Cognitive insight did not significantly correlate with social or role functioning, or depression. Cognitive insight scores did not significantly differ between baseline and 1-month follow-up. Discussion: These findings provide little evidence for a relation between cognitive insight and clinical and functional variables in CHR, and suggest that cognitive insight remains stable over a 1-month time period in our sample. These data add to a growing body of literature on cognitive insight across the schizophrenia spectrum
Activation and Complex Regulation of the Kef Potassium Efflux System During Protection of Bacteria Against Toxic Electrophiles
Patterns of premorbid functioning in individuals at clinical high risk of psychosis
In schizophrenia, four typical patterns of premorbid functioning have been observed: stable-good, stable-intermediate, poor-deteriorating and deteriorating. However, it is unknown whether similar patterns exist in those who are at clinical high risk (CHR) of psychosis. The aim of this study was to examine patterns of premorbid functioning in a large sample of individuals at CHR of psychosis and its association with symptoms, functioning, and conversion to psychosis. One-hundred sixty people at CHR of psychosis were assessed on premorbid functioning using the Premorbid Adjustment Scale. Poorer premorbid functioning was significantly correlated with worse negative symptom severity and lower social functioning. Cluster analysis was used to identify patterns of premorbid functioning. Results indicated three patterns of premorbid functioning in our CHR sample: stable-intermediate, stable-good, and deteriorating. The deteriorating group had more severe disorganization, worse negative symptoms and poorer social functioning than the other groups. Participants who made the conversion to psychosis had significantly poorer premorbid functioning during adolescence compared to those who did not convert. These results suggest that those at a clinical high risk for psychosis display similar patterns in premorbid functioning as have been observed in those with a psychotic illness and that poor premorbid functioning may be a predictor of psychosis
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
A Genome-Wide Association Study Finds Genetic Associations with Broadly-Defined Headache in UK Biobank (N = 223,773)
Background: Headache is the most common neurological symptom and a leading cause of years lived with disability. We sought to identify the genetic variants associated with a broadly-defined headache phenotype in 223,773 subjects from the UK Biobank cohort.
Methods: We defined headache based on a specific question answered by the UK Biobank participants. We performed a genome-wide association study of headache as a single entity, using 74,461 cases and 149,312 controls.
Results: We identified 3343 SNPs which reached the genome-wide significance level of PÂ <Â 5Â ĂÂ 10â8. The SNPs were located in 28 loci, with the top SNP of rs11172113 in the LRP1 gene having a P value of 4.92Â ĂÂ 10â47. Of the 28 loci, 14 have previously been associated with migraine. Among 14 new loci, rs77804065 with a P value of 5.87Â ĂÂ 10â15 in the LINC02210-CRHR1 gene was the top SNP. Significant relationships between multiple brain tissues and genetic associations were identified through tissue expression analysis. We also identified significant positive genetic correlations between headache and many psychological traits.
Conclusions: Our results suggest that brain function is closely related to broadly-defined headache. In addition, we found that many psychological traits have genetic correlations with headache
Personality Characteristics of Male Sufferers of Chronic Tension-Type and Cervicogenic Headache
A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study
The aim of this study was to evaluate the long-term outcome in 61 patients with medication-overuse headache (MOH) who 4 years previously had been included in a randomized open-label prospective multicentre study. Sixty patients still alive after 4 years were invited to a follow-up investigation. Fifty patients (83%) participated. Sixteen visited a neurologist, 22 were interviewed through telephone, 2 gave response by a letter, and 10 were evaluated through hospital records. The influence of baseline characteristics on outcome 4 years later was evaluated by non-parametric tests. p values below 0.01 were considered significant. At follow-up, the 50 persons had a mean reduction of 6.5 headache days/month (p < 0.001) and 9.5 acute headache medication days/month (p < 0.001) compared to baseline. Headache index/month was reduced from 449 to 321 (p < 0.001). Sixteen persons (32%) were considered as responders due to a âĽ50% reduction in headache frequency from baseline, whereas 17 (34%) persons met the criteria for MOH. None of the baseline characteristics consistently influenced all five outcome measures. Total Hospital Anxiety and Depression Scale (HADS) score at baseline was predictors (p < 0.005) for being a responder after 4 years. At 4 yearsâ follow-up, one-third of the 50 MOH patients had âĽ50% reduction in headache frequency from baseline. A low total HADS score at baseline was associated with the most favorable outcome
Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012
Headache and facial pain are among the most common, disabling and costly disorders in Europe. Correct diagnosis and treatment is important for achieving a high quality of care. As a national organisation whose role is to educate and advocate for the needs of patients with primary headaches, the Danish Headache Society has set up a task force to develop a set of guidelines for the diagnosis, organisation and treatment of the most common types of headaches and for trigeminal neuralgia in Denmark. The guideline was published in Danish in 2010 and has been a great success. The Danish Headache Society decided to translate and publish our guideline in English to stimulate the discussion on optimal organisation and treatment of headache disorders and to encourage other national headache authorities to produce their own guidelines. The recommendations regarding the most common primary headaches and trigeminal neuralgia are largely in accordance with the European guidelines produced by the European Federation of Neurological Societies. The guideline provides a practical tool for use in daily clinical practice for primary care physicians, neurologists with a common interest in headache, as well as other health-care professionals treating headache patients. The guideline first describes how to examine and diagnose the headache patient and how headache treatment is organised in Denmark. This description is followed by individual sections on the characteristics, diagnosis, differential diagnosis and treatment of each of the major headache disorders and trigeminal neuralgia. The guideline includes many tables to facilitate a quick overview. Finally, the particular problems regarding headache in children and headache in relation to female hormones and pregnancy are described
- âŚ